310 related articles for article (PubMed ID: 25448466)
1. Sputum containing zinc enhances carbapenem resistance, biofilm formation and virulence of Pseudomonas aeruginosa.
Marguerettaz M; Dieppois G; Que YA; Ducret V; Zuchuat S; Perron K
Microb Pathog; 2014 Dec; 77():36-41. PubMed ID: 25448466
[TBL] [Abstract][Full Text] [Related]
2. Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy.
Wolter DJ; Acquazzino D; Goering RV; Sammut P; Khalaf N; Hanson ND
Clin Infect Dis; 2008 Jun; 46(12):e137-41. PubMed ID: 18462098
[TBL] [Abstract][Full Text] [Related]
3. Carbapenem resistance in cystic fibrosis strains of Pseudomonas aeruginosa as a result of amino acid substitutions in porin OprD.
Richardot C; Plésiat P; Fournier D; Monlezun L; Broutin I; Llanes C
Int J Antimicrob Agents; 2015 May; 45(5):529-32. PubMed ID: 25735764
[TBL] [Abstract][Full Text] [Related]
4. Small colony variants of Pseudomonas aeruginosa in chronic bacterial infection of the lung in cystic fibrosis.
Evans TJ
Future Microbiol; 2015; 10(2):231-9. PubMed ID: 25689535
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for mortality in patients with bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa: clinical impact of bacterial virulence and strains on outcome.
Jeong SJ; Yoon SS; Bae IK; Jeong SH; Kim JM; Lee K
Diagn Microbiol Infect Dis; 2014 Oct; 80(2):130-5. PubMed ID: 25112900
[TBL] [Abstract][Full Text] [Related]
6. A copper-activated two-component system interacts with zinc and imipenem resistance in Pseudomonas aeruginosa.
Caille O; Rossier C; Perron K
J Bacteriol; 2007 Jul; 189(13):4561-8. PubMed ID: 17449606
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
[TBL] [Abstract][Full Text] [Related]
8. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.
Diene SM; L'homme T; Bellulo S; Stremler N; Dubus JC; Mely L; Leroy S; Degand N; Rolain JM
Int J Antimicrob Agents; 2013 Sep; 42(3):268-71. PubMed ID: 23880169
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
Murray TS; Egan M; Kazmierczak BI
Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
[TBL] [Abstract][Full Text] [Related]
10. Calprotectin-Mediated Zinc Chelation Inhibits Pseudomonas aeruginosa Protease Activity in Cystic Fibrosis Sputum.
Vermilyea DM; Crocker AW; Gifford AH; Hogan DA
J Bacteriol; 2021 Jun; 203(13):e0010021. PubMed ID: 33927050
[TBL] [Abstract][Full Text] [Related]
11. Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung.
Kirchner S; Fothergill JL; Wright EA; James CE; Mowat E; Winstanley C
J Vis Exp; 2012 Jun; (64):e3857. PubMed ID: 22711026
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas aeruginosa biofilms in cystic fibrosis.
Høiby N; Ciofu O; Bjarnsholt T
Future Microbiol; 2010 Nov; 5(11):1663-74. PubMed ID: 21133688
[TBL] [Abstract][Full Text] [Related]
13. Biofilm production using distinct media and antimicrobial susceptibility profile of Pseudomonas aeruginosa.
Perez LR; Barth AL
Braz J Infect Dis; 2011; 15(4):301-4. PubMed ID: 21860998
[TBL] [Abstract][Full Text] [Related]
14. Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa.
Halwani M; Hebert S; Suntres ZE; Lafrenie RM; Azghani AO; Omri A
Int J Pharm; 2009 May; 373(1-2):141-6. PubMed ID: 19429299
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and Genotypic Adaptations in Pseudomonas aeruginosa Biofilms following Long-Term Exposure to an Alginate Oligomer Therapy.
Oakley JL; Weiser R; Powell LC; Forton J; Mahenthiralingam E; Rye PD; Hill KE; Thomas DW; Pritchard MF
mSphere; 2021 Jan; 6(1):. PubMed ID: 33472983
[TBL] [Abstract][Full Text] [Related]
16. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms.
Singh PK; Schaefer AL; Parsek MR; Moninger TO; Welsh MJ; Greenberg EP
Nature; 2000 Oct; 407(6805):762-4. PubMed ID: 11048725
[TBL] [Abstract][Full Text] [Related]
17. Evolutionary diversification of Pseudomonas aeruginosa in an artificial sputum model.
Davies EV; James CE; Brockhurst MA; Winstanley C
BMC Microbiol; 2017 Jan; 17(1):3. PubMed ID: 28056789
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors.
Nafee N; Husari A; Maurer CK; Lu C; de Rossi C; Steinbach A; Hartmann RW; Lehr CM; Schneider M
J Control Release; 2014 Oct; 192():131-40. PubMed ID: 24997276
[TBL] [Abstract][Full Text] [Related]
19. Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.
Schneider-Futschik EK; Paulin OKA; Hoyer D; Roberts KD; Ziogas J; Baker MA; Karas J; Li J; Velkov T
ACS Infect Dis; 2018 May; 4(5):646-655. PubMed ID: 29566483
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
Tré-Hardy M; Traore H; El Manssouri N; Vanderbist F; Vaneechoutte M; Devleeschouwer MJ
Int J Antimicrob Agents; 2009 Oct; 34(4):370-4. PubMed ID: 19505804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
